AI Tokens
Stock Analysis on Net

Financial statement analysis and common stock valuation

If you are an investor who values fundamental analysis, you are in the right place. If you need comprehensive financial ratios, read on. You already know that the analysis of financial statements allows you to buy cheap and sell high, now it’s time to put it into practice. Stock Analysis on Net is here for you.

Example company for today:

NVIDIA Corp. (NASDAQ:NVDA)

Long-term Trends

Common-Size Income Statement

Income statement components (revenues and expenses) shown as percentage of total sales.

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Liabilities and stockholders’ equity components shown as percentage of total liabilities and stockholders’ equity.

Common Stock Valuation Ratios

Relative valuation technique determine the value of NVIDIA Corp. by comparing it to similar entities (like industry or sector) on the basis of several relative ratios that compare its stock price to relevant variables that affect the stock value, such as earnings, book value, and sales.

Enterprise Value to FCFF (EV/FCFF)

Free cash flow to the firm is the cash flow available to the NVIDIA Corp. suppliers of capital after all operating expenses have been paid and necessary investments in working and fixed capital have been made.

Common-Size Income Statement
Quarterly Data

Income statement components (revenues and expenses) shown as percentage of total sales.

More


What’s new

Tuesday, November 3, 2026

Apple Inc. (NASDAQ:AAPL) annual report
for fiscal year ended September 26, 2026

Tuesday, November 3, 2026

AbbVie Inc. (NYSE:ABBV) quarterly report
for quarterly period ended September 30, 2026

Tuesday, November 3, 2026

Palantir Technologies Inc. (NASDAQ:PLTR) quarterly report
for quarterly period ended September 30, 2026

Tuesday, November 3, 2026

UnitedHealth Group Inc. (NYSE:UNH) quarterly report
for quarterly period ended September 30, 2026

Tuesday, November 3, 2026

Pfizer Inc. (NYSE:PFE) quarterly report
for quarterly period ended September 27, 2026

Tuesday, November 3, 2026

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) quarterly report
for quarterly period ended September 30, 2026

More


Most visited companies…